You are here

lifileucel

FDA capacity forces delay to Iovance's cell therapy

Pharmaphorum

Fri, 09/15/23 - 11:47 am

Iovance Biotherapeutics

Iovance looks to advance its non-small cell lung cancer therapy

Clinical Trials Arena

Tue, 07/11/23 - 10:17 am

Iovance Biotherapeutics

clinical trials

tumor-infiltrating lymphocyte therapy

non-small cell lung cancer

Iovance's BLA for Advanced Melanoma Therapeutic Delayed Until Q1 2023

BioSpace

Fri, 11/18/22 - 10:25 am

metastatic melanoma

Iovance Biotherapeutics CEO Fardis departs following FDA setback for lead drug lifileucel

Fierce Biotech

Wed, 05/19/21 - 11:04 pm

Iovance Continues Path in Developing TIL Treatments for Solid Tumors

BioSpace

Fri, 08/17/18 - 09:39 am